RoosterBio’s xeno-free hUC-MSCs, isolated from the perivascular Wharton’s Jelly region of the human umbilical cord and manufactured with cGMP compatible processes, contain >10 million viable xeno-free hMSCs from a single healthy donor at a population doubling level of 15 to 18.
When used as a complete hUC-MSC bioprocessing system along with RBI’s 2D Batch or 3D Bioreactor Fed-Batch process recommendations and RoosterNourish™-MSC-XF each vial can produce >5 billion high-quality hMSCs within 8 -10 days. Each produced lot comes with RoosterBio’s first-in-class testing and characterization of hUC-MSC key quality attributes (identity and expansion potential) as well as functional profile (cytokine secretion, trilineage differentiation, and immunomodulation) - giving added confidence in quality, reproducibility, and ease of integration of while “Radically Simplifying” your hUC-MSC product development.
RoosterVial-hUC-XF manufactured and sold by RoosterBio, INC and supported by licensed technology from Tissue Regeneration Therapeutics Inc. (TRT) core technology and patent family: US 8,790,923; US 8,278,102; US 7,547,546; US 9,611,456; US 9,611,456; US 8,481,311; US 9,611,456. Access fees and license opportunities may apply.
Contact us at firstname.lastname@example.org for process recommendations.